The document discusses the transformative potential of artificial intelligence in healthcare, highlighting its applications in predicting drug outcomes and assisting medication adherence. It mentions collaborations between major companies, such as IBM and Johnson & Johnson, to enhance drug development, and explores the use of AI for supporting Alzheimer’s patients. Additionally, it notes the rapid advancements in machine learning systems and the growing investment in AI startups within the healthcare sector.
Related topics: